Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Citi
UBS
Queensland Health
Covington
Teva
Chinese Patent Office
Daiichi Sankyo
Argus Health

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040069

« Back to Dashboard
NDA 040069 describes DEXAMETHASONE SODIUM PHOSPHATE, which is a drug marketed by Mylan Labs Ltd, Watson Labs, West-ward Pharms Int, Fresenius Kabi Usa, Intl Medication, Teva Parenteral, Luitpold, Wyeth Ayerst, Bel Mar, Akorn, Dell Labs, Lyphomed, Bausch And Lomb, Sola Barnes Hind, Sandoz Inc, and Aurobindo Pharma Ltd, and is included in twenty-eight NDAs. It is available from twenty-one suppliers. Additional details are available on the DEXAMETHASONE SODIUM PHOSPHATE profile page.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

Summary for NDA: 040069

Pharmacology for NDA: 040069

Suppliers and Packaging for NDA: 040069

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC, OTIC 040069 ANDA Major Pharmaceuticals 0904-3006 0904-3006-05 1 BOTTLE, DROPPER in 1 CARTON (0904-3006-05) > 5 mL in 1 BOTTLE, DROPPER
DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC, OTIC 040069 ANDA Butler Animal Health Supply 11695-1411 11695-1411-2 1 BOTTLE, DROPPER in 1 CARTON (11695-1411-2) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMIC, OTICStrengthEQ 0.1% PHOSPHATE
Approval Date:Jul 26, 1996TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Dow
Merck
Fuji
UBS
Fish and Richardson
McKinsey
Deloitte
McKesson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot